Endothelial response to blood-brain barrier disruption in the human brain

Cerebral endothelial cell (EC) injury and blood-brain barrier (BBB) permeability contribute to neuronal injury in acute neurological disease states. Preclinical experiments have used animal models to study this phenomenon, yet the response of human cerebral ECs to BBB disruption remains unclear. In...

Full description

Saved in:
Bibliographic Details
Published inJCI insight Vol. 10; no. 4
Main Authors Gould, Andrew, Luan, Yu, Hou, Ye, Korobova, Farida V., Chen, Li, Arrieta, Victor A., Amidei, Christina, Ward, Rachel, Gomez, Cristal, Castro, Brandyn, Habashy, Karl, Zhang, Daniel, Youngblood, Mark, Dmello, Crismita, Bebawy, John, Bouchoux, Guillaume, Stupp, Roger, Canney, Michael, Yue, Feng, Iruela-Arispe, M. Luisa, Sonabend, Adam M.
Format Journal Article
LanguageEnglish
Published United States American Society for Clinical Investigation 24.02.2025
American Society for Clinical investigation
Subjects
Online AccessGet full text
ISSN2379-3708
2379-3708
DOI10.1172/jci.insight.187328

Cover

Abstract Cerebral endothelial cell (EC) injury and blood-brain barrier (BBB) permeability contribute to neuronal injury in acute neurological disease states. Preclinical experiments have used animal models to study this phenomenon, yet the response of human cerebral ECs to BBB disruption remains unclear. In our phase I clinical trial (ClinicalTrials.gov NCT04528680), we used low-intensity pulsed ultrasound with microbubbles (LIPU/MB) to induce transient BBB disruption of peritumoral brain in patients with recurrent glioblastoma. We found radiographic evidence that BBB integrity was mostly restored within 1 hour of this procedure. Using single-cell RNA sequencing and transmission electron microscopy, we analyzed the acute response of human brain ECs to ultrasound-mediated BBB disruption. Our analysis revealed distinct EC gene expression changes after LIPU/MB, particularly in genes related to neurovascular barrier function and structure, including changes to genes involved in the basement membrane, EC cytoskeleton, and junction complexes, as well as caveolar transcytosis and various solute transporters. Ultrastructural analysis showed that LIPU/MB led to a decrease in luminal caveolae, the emergence of cytoplasmic vacuoles, and the disruption of the basement membrane and tight junctions, among other things. These findings suggested that acute BBB disruption by LIPU/MB led to specific transcriptional and ultrastructural changes and could represent a conserved mechanism of BBB repair after neurovascular injury in humans.
AbstractList Cerebral endothelial cell (EC) injury and blood-brain barrier (BBB) permeability contribute to neuronal injury in acute neurological disease states. Preclinical experiments have used animal models to study this phenomenon, yet the response of human cerebral ECs to BBB disruption remains unclear. In our phase I clinical trial (ClinicalTrials.gov NCT04528680), we used low-intensity pulsed ultrasound with microbubbles (LIPU/MB) to induce transient BBB disruption of peritumoral brain in patients with recurrent glioblastoma. We found radiographic evidence that BBB integrity was mostly restored within 1 hour of this procedure. Using single-cell RNA sequencing and transmission electron microscopy, we analyzed the acute response of human brain ECs to ultrasound-mediated BBB disruption. Our analysis revealed distinct EC gene expression changes after LIPU/MB, particularly in genes related to neurovascular barrier function and structure, including changes to genes involved in the basement membrane, EC cytoskeleton, and junction complexes, as well as caveolar transcytosis and various solute transporters. Ultrastructural analysis showed that LIPU/MB led to a decrease in luminal caveolae, the emergence of cytoplasmic vacuoles, and the disruption of the basement membrane and tight junctions, among other things. These findings suggested that acute BBB disruption by LIPU/MB led to specific transcriptional and ultrastructural changes and could represent a conserved mechanism of BBB repair after neurovascular injury in humans. Targeted ultrasound is used to study how human cerebral endothelial cells respond to acute blood-brain barrier disruption.
Cerebral endothelial cell (EC) injury and blood-brain barrier (BBB) permeability contribute to neuronal injury in acute neurological disease states. Preclinical experiments have used animal models to study this phenomenon, yet the response of human cerebral ECs to BBB disruption remains unclear. In our phase I clinical trial (ClinicalTrials.gov NCT04528680), we used low-intensity pulsed ultrasound with microbubbles (LIPU/MB) to induce transient BBB disruption of peritumoral brain in patients with recurrent glioblastoma. We found radiographic evidence that BBB integrity was mostly restored within 1 hour of this procedure. Using single-cell RNA sequencing and transmission electron microscopy, we analyzed the acute response of human brain ECs to ultrasound-mediated BBB disruption. Our analysis revealed distinct EC gene expression changes after LIPU/MB, particularly in genes related to neurovascular barrier function and structure, including changes to genes involved in the basement membrane, EC cytoskeleton, and junction complexes, as well as caveolar transcytosis and various solute transporters. Ultrastructural analysis showed that LIPU/MB led to a decrease in luminal caveolae, the emergence of cytoplasmic vacuoles, and the disruption of the basement membrane and tight junctions, among other things. These findings suggested that acute BBB disruption by LIPU/MB led to specific transcriptional and ultrastructural changes and could represent a conserved mechanism of BBB repair after neurovascular injury in humans.Cerebral endothelial cell (EC) injury and blood-brain barrier (BBB) permeability contribute to neuronal injury in acute neurological disease states. Preclinical experiments have used animal models to study this phenomenon, yet the response of human cerebral ECs to BBB disruption remains unclear. In our phase I clinical trial (ClinicalTrials.gov NCT04528680), we used low-intensity pulsed ultrasound with microbubbles (LIPU/MB) to induce transient BBB disruption of peritumoral brain in patients with recurrent glioblastoma. We found radiographic evidence that BBB integrity was mostly restored within 1 hour of this procedure. Using single-cell RNA sequencing and transmission electron microscopy, we analyzed the acute response of human brain ECs to ultrasound-mediated BBB disruption. Our analysis revealed distinct EC gene expression changes after LIPU/MB, particularly in genes related to neurovascular barrier function and structure, including changes to genes involved in the basement membrane, EC cytoskeleton, and junction complexes, as well as caveolar transcytosis and various solute transporters. Ultrastructural analysis showed that LIPU/MB led to a decrease in luminal caveolae, the emergence of cytoplasmic vacuoles, and the disruption of the basement membrane and tight junctions, among other things. These findings suggested that acute BBB disruption by LIPU/MB led to specific transcriptional and ultrastructural changes and could represent a conserved mechanism of BBB repair after neurovascular injury in humans.
Cerebral endothelial cell (EC) injury and blood-brain barrier (BBB) permeability contribute to neuronal injury in acute neurological disease states. Preclinical experiments have used animal models to study this phenomenon, yet the response of human cerebral ECs to BBB disruption remains unclear. In our phase I clinical trial (ClinicalTrials.gov NCT04528680), we used low-intensity pulsed ultrasound with microbubbles (LIPU/MB) to induce transient BBB disruption of peritumoral brain in patients with recurrent glioblastoma. We found radiographic evidence that BBB integrity was mostly restored within 1 hour of this procedure. Using single-cell RNA sequencing and transmission electron microscopy, we analyzed the acute response of human brain ECs to ultrasound-mediated BBB disruption. Our analysis revealed distinct EC gene expression changes after LIPU/MB, particularly in genes related to neurovascular barrier function and structure, including changes to genes involved in the basement membrane, EC cytoskeleton, and junction complexes, as well as caveolar transcytosis and various solute transporters. Ultrastructural analysis showed that LIPU/MB led to a decrease in luminal caveolae, the emergence of cytoplasmic vacuoles, and the disruption of the basement membrane and tight junctions, among other things. These findings suggested that acute BBB disruption by LIPU/MB led to specific transcriptional and ultrastructural changes and could represent a conserved mechanism of BBB repair after neurovascular injury in humans.
Author Hou, Ye
Canney, Michael
Bouchoux, Guillaume
Bebawy, John
Amidei, Christina
Stupp, Roger
Chen, Li
Dmello, Crismita
Korobova, Farida V.
Ward, Rachel
Iruela-Arispe, M. Luisa
Sonabend, Adam M.
Zhang, Daniel
Yue, Feng
Gomez, Cristal
Arrieta, Victor A.
Gould, Andrew
Castro, Brandyn
Youngblood, Mark
Luan, Yu
Habashy, Karl
AuthorAffiliation 3 Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
10 Department of Neurology and
7 Rush Medical College, Chicago, Illinois, USA
8 Department of Anesthesiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
1 Department of Neurological Surgery
6 Department of Neurosurgery, University of Chicago, Chicago, Illinois, USA
11 Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
4 Institute of Biomedicine, College of Life Sciences, Inner Mongolia University, Hohhot, China
9 Carthera, Lyon, France
2 Northwestern Medicine Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, and
5 Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
AuthorAffiliation_xml – name: 2 Northwestern Medicine Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, and
– name: 3 Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
– name: 7 Rush Medical College, Chicago, Illinois, USA
– name: 8 Department of Anesthesiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
– name: 1 Department of Neurological Surgery
– name: 6 Department of Neurosurgery, University of Chicago, Chicago, Illinois, USA
– name: 4 Institute of Biomedicine, College of Life Sciences, Inner Mongolia University, Hohhot, China
– name: 10 Department of Neurology and
– name: 5 Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
– name: 11 Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
– name: 9 Carthera, Lyon, France
Author_xml – sequence: 1
  givenname: Andrew
  surname: Gould
  fullname: Gould, Andrew
– sequence: 2
  givenname: Yu
  surname: Luan
  fullname: Luan, Yu
– sequence: 3
  givenname: Ye
  surname: Hou
  fullname: Hou, Ye
– sequence: 4
  givenname: Farida V.
  surname: Korobova
  fullname: Korobova, Farida V.
– sequence: 5
  givenname: Li
  surname: Chen
  fullname: Chen, Li
– sequence: 6
  givenname: Victor A.
  orcidid: 0000-0003-2738-9741
  surname: Arrieta
  fullname: Arrieta, Victor A.
– sequence: 7
  givenname: Christina
  surname: Amidei
  fullname: Amidei, Christina
– sequence: 8
  givenname: Rachel
  surname: Ward
  fullname: Ward, Rachel
– sequence: 9
  givenname: Cristal
  surname: Gomez
  fullname: Gomez, Cristal
– sequence: 10
  givenname: Brandyn
  surname: Castro
  fullname: Castro, Brandyn
– sequence: 11
  givenname: Karl
  surname: Habashy
  fullname: Habashy, Karl
– sequence: 12
  givenname: Daniel
  orcidid: 0000-0001-9962-9295
  surname: Zhang
  fullname: Zhang, Daniel
– sequence: 13
  givenname: Mark
  orcidid: 0000-0002-1044-8015
  surname: Youngblood
  fullname: Youngblood, Mark
– sequence: 14
  givenname: Crismita
  orcidid: 0000-0002-1688-9663
  surname: Dmello
  fullname: Dmello, Crismita
– sequence: 15
  givenname: John
  surname: Bebawy
  fullname: Bebawy, John
– sequence: 16
  givenname: Guillaume
  surname: Bouchoux
  fullname: Bouchoux, Guillaume
– sequence: 17
  givenname: Roger
  orcidid: 0000-0002-5483-3118
  surname: Stupp
  fullname: Stupp, Roger
– sequence: 18
  givenname: Michael
  surname: Canney
  fullname: Canney, Michael
– sequence: 19
  givenname: Feng
  surname: Yue
  fullname: Yue, Feng
– sequence: 20
  givenname: M. Luisa
  orcidid: 0000-0002-3050-4168
  surname: Iruela-Arispe
  fullname: Iruela-Arispe, M. Luisa
– sequence: 21
  givenname: Adam M.
  surname: Sonabend
  fullname: Sonabend, Adam M.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39724015$$D View this record in MEDLINE/PubMed
BookMark eNpVkU9r3DAQxUVJadIkXyCH4GMv3mokWbJPpYS0XQj00pzF6I93tXilrWQX-u2jdLchQYcRM29-D-Z9JGcxRU_IDdAVgGKfdzasQixhs51X0CvO-nfkgnE1tFzR_uzV_5xcl7KjlIISjHb9B3LOB8UEhe6CrO-jS_PWTwGnJvtySLH4Zk6NmVJyrckYYmMw5-Bz40LJy2EOKTa1W7ea7bLHOn9WXZH3I07FX5_qJXn8dv_r7kf78PP7-u7rQ2ur-9yiBRSDlRYoMwIV2M54y7gQSnJqeH3CjVQ41Xs7WGuFga4DK3vP0bOeX5L1kesS7vQhhz3mvzph0P8aKW805jnYyeuul9yOTHocjQCGBiUADBTZIJ2TUFlfjqzDYvbeWR_njNMb6NtJDFu9SX90pYiBSlEJn06EnH4vvsx6H4r104TRp6VoDmLo6ql7XqW3r81eXP6HUQXsKLA5lZL9-CIBqp9D1zV0fQpdH0PnTzi_ovk
Cites_doi 10.1016/j.neuropharm.2018.06.007
10.1007/s00424-013-1342-9
10.1084/jem.20190062
10.1016/j.neuron.2014.03.003
10.1093/neuonc/noae135
10.1158/1078-0432.CCR-19-2182
10.3390/ijms21093344
10.1038/s41598-020-69096-7
10.1152/physrev.00050.2017
10.1093/database/baz046
10.1038/s41588-020-00721-x
10.3389/fphys.2020.00973
10.7863/ultra.16.02005
10.1038/ncomms10523
10.1016/S1470-2045(23)00112-2
10.1016/j.cels.2019.03.003
10.1016/j.yao.2023.01.017
10.1038/srep33264
10.1038/s41593-018-0079-3
10.1158/1078-0432.CCR-18-3643
10.3390/pharmaceutics13060834
10.1126/scitranslmed.aaf6086
10.1128/MCB.01909-06
10.1126/science.abi7377
10.3389/fneur.2021.729464
10.1096/fj.201600827R
10.1038/ncb1293
10.1007/s11060-019-03204-0
10.1177/0271678X16670922
10.1083/jcb.138.4.877
10.1038/s41592-019-0619-0
10.1038/nature25739
10.1038/jcbfm.2014.199
10.1161/JAHA.117.005811
10.1016/j.neuroimage.2004.06.046
10.1016/j.neuron.2017.03.043
10.1177/0271678X15608396
10.1038/nature13324
10.1038/s41593-019-0497-x
10.1177/0271678X15609331
10.1007/s12975-019-00775-y
10.1080/21688370.2016.1154641
10.1177/0271678X17722436
10.1152/ajpcell.1998.274.4.C1101
10.1083/jcb.201404140
10.1016/j.ultrasmedbio.2004.04.010
10.1038/s41592-021-01060-3
10.1161/CIRCULATIONAHA.114.013395
10.1038/s41467-024-45818-7
10.7150/thno.94206
10.1038/s41467-024-48326-w
10.2174/1570159X16666180222164809
10.1016/j.cell.2010.12.031
10.1038/s41593-020-00794-1
10.1101/2023.03.31.535150
10.1089/omi.2011.0118
10.1186/2045-8118-9-23
10.1038/s41598-018-36340-0
10.1016/j.ultrasmedbio.2006.05.015
10.1111/j.1749-6632.2012.06506.x
10.1136/svn-2018-000198
10.1038/clpt.2013.175
10.3390/ijms231911222
10.1016/j.cell.2019.05.006
10.1007/s00401-018-1824-0
10.1038/nbt.3192
ContentType Journal Article
Copyright 2025 Gould et al. 2025 Gould et al.
Copyright_xml – notice: 2025 Gould et al. 2025 Gould et al.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1172/jci.insight.187328
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2379-3708
ExternalDocumentID oai_doaj_org_article_5863cf26eafb412aba611190a296dd61
PMC11949064
39724015
10_1172_jci_insight_187328
Genre Journal Article
Clinical Trial, Phase I
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: U19 CA264338
– fundername: NCI NIH HHS
  grantid: R01 CA245969
– fundername: NINDS NIH HHS
  grantid: R01 NS110703
– fundername: NCI NIH HHS
  grantid: P30 CA060553
– fundername: NCI NIH HHS
  grantid: P50 CA221747
– fundername: ;
  grantid: P50CA221747
– fundername: ;
  grantid: 1R01NS110703-01A1,1U19CA264338-01,1R01CA245969-01A1
GroupedDBID 53G
AAFWJ
AAYXX
ADBBV
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
CITATION
GROUPED_DOAJ
HYE
M~E
OK1
RPM
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c420t-ac1a49c6c102b4a71c5bec23447630b3b3b4df04d78ec9ccc4b1551c68e3ae283
IEDL.DBID DOA
ISSN 2379-3708
IngestDate Mon Sep 15 19:43:04 EDT 2025
Thu Aug 21 18:39:40 EDT 2025
Thu Jul 10 23:49:48 EDT 2025
Wed Jun 18 01:41:26 EDT 2025
Sun Jul 06 05:03:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Neuroscience
Endothelial cells
Vascular biology
Language English
License http://creativecommons.org/licenses/by/4.0
This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c420t-ac1a49c6c102b4a71c5bec23447630b3b3b4df04d78ec9ccc4b1551c68e3ae283
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-3050-4168
0000-0002-1688-9663
0000-0003-2738-9741
0000-0002-1044-8015
0000-0001-9962-9295
0000-0002-5483-3118
OpenAccessLink https://doaj.org/article/5863cf26eafb412aba611190a296dd61
PMID 39724015
PQID 3149540183
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_5863cf26eafb412aba611190a296dd61
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11949064
proquest_miscellaneous_3149540183
pubmed_primary_39724015
crossref_primary_10_1172_jci_insight_187328
PublicationCentury 2000
PublicationDate 2025-02-24
PublicationDateYYYYMMDD 2025-02-24
PublicationDate_xml – month: 02
  year: 2025
  text: 2025-02-24
  day: 24
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JCI insight
PublicationTitleAlternate JCI Insight
PublicationYear 2025
Publisher American Society for Clinical Investigation
American Society for Clinical investigation
Publisher_xml – name: American Society for Clinical Investigation
– name: American Society for Clinical investigation
References B20
B64
B21
B65
B22
B66
B23
B24
B25
B26
B27
B28
B29
B30
B31
B32
B33
B34
B35
B36
B37
B38
B39
B1
B2
B3
B4
B5
B6
B7
B8
B9
B40
B41
B42
B43
B44
B45
B46
B47
B48
B49
B50
B51
B52
B53
B10
B54
B11
B55
B12
B56
B13
B57
B14
B58
B15
B59
B16
B17
B18
B19
B60
B61
B62
B63
References_xml – ident: B27
  doi: 10.1016/j.neuropharm.2018.06.007
– ident: B34
  doi: 10.1007/s00424-013-1342-9
– ident: B1
  doi: 10.1084/jem.20190062
– ident: B11
  doi: 10.1016/j.neuron.2014.03.003
– ident: B23
  doi: 10.1093/neuonc/noae135
– ident: B22
  doi: 10.1158/1078-0432.CCR-19-2182
– ident: B9
  doi: 10.3390/ijms21093344
– ident: B37
  doi: 10.1038/s41598-020-69096-7
– ident: B2
  doi: 10.1152/physrev.00050.2017
– ident: B61
  doi: 10.1093/database/baz046
– ident: B62
  doi: 10.1038/s41588-020-00721-x
– ident: B31
  doi: 10.3389/fphys.2020.00973
– ident: B57
  doi: 10.7863/ultra.16.02005
– ident: B45
  doi: 10.1038/ncomms10523
– ident: B24
  doi: 10.1016/S1470-2045(23)00112-2
– ident: B59
  doi: 10.1016/j.cels.2019.03.003
– ident: B20
  doi: 10.1016/j.yao.2023.01.017
– ident: B55
  doi: 10.1038/srep33264
– ident: B63
  doi: 10.1038/s41593-018-0079-3
– ident: B56
  doi: 10.1158/1078-0432.CCR-18-3643
– ident: B36
  doi: 10.3390/pharmaceutics13060834
– ident: B18
  doi: 10.1126/scitranslmed.aaf6086
– ident: B28
  doi: 10.1128/MCB.01909-06
– ident: B50
  doi: 10.1126/science.abi7377
– ident: B10
  doi: 10.3389/fneur.2021.729464
– ident: B30
  doi: 10.1096/fj.201600827R
– ident: B54
  doi: 10.1038/ncb1293
– ident: B19
  doi: 10.1007/s11060-019-03204-0
– ident: B7
  doi: 10.1177/0271678X16670922
– ident: B29
  doi: 10.1083/jcb.138.4.877
– ident: B60
  doi: 10.1038/s41592-019-0619-0
– ident: B49
  doi: 10.1038/nature25739
– ident: B14
  doi: 10.1038/jcbfm.2014.199
– ident: B46
  doi: 10.1161/JAHA.117.005811
– ident: B51
  doi: 10.1016/j.neuroimage.2004.06.046
– ident: B3
  doi: 10.1016/j.neuron.2017.03.043
– ident: B12
  doi: 10.1177/0271678X15608396
– ident: B4
  doi: 10.1038/nature13324
– ident: B15
  doi: 10.1038/s41593-019-0497-x
– ident: B33
  doi: 10.1177/0271678X15609331
– ident: B47
  doi: 10.1007/s12975-019-00775-y
– ident: B6
  doi: 10.1080/21688370.2016.1154641
– ident: B13
  doi: 10.1177/0271678X17722436
– ident: B32
  doi: 10.1152/ajpcell.1998.274.4.C1101
– ident: B44
  doi: 10.1083/jcb.201404140
– ident: B38
  doi: 10.1016/j.ultrasmedbio.2004.04.010
– ident: B65
  doi: 10.1038/s41592-021-01060-3
– ident: B40
  doi: 10.1161/CIRCULATIONAHA.114.013395
– ident: B25
  doi: 10.1038/s41467-024-45818-7
– ident: B17
  doi: 10.7150/thno.94206
– ident: B26
  doi: 10.1038/s41467-024-48326-w
– ident: B42
  doi: 10.2174/1570159X16666180222164809
– ident: B53
  doi: 10.1016/j.cell.2010.12.031
– ident: B48
  doi: 10.1038/s41593-020-00794-1
– ident: B16
  doi: 10.1101/2023.03.31.535150
– ident: B66
  doi: 10.1089/omi.2011.0118
– ident: B5
  doi: 10.1186/2045-8118-9-23
– ident: B21
  doi: 10.1038/s41598-018-36340-0
– ident: B39
  doi: 10.1016/j.ultrasmedbio.2006.05.015
– ident: B43
  doi: 10.1111/j.1749-6632.2012.06506.x
– ident: B41
  doi: 10.1136/svn-2018-000198
– ident: B35
  doi: 10.1038/clpt.2013.175
– ident: B52
  doi: 10.3390/ijms231911222
– ident: B64
  doi: 10.1016/j.cell.2019.05.006
– ident: B8
  doi: 10.1007/s00401-018-1824-0
– ident: B58
  doi: 10.1038/nbt.3192
SSID ssj0001742058
Score 2.3076968
Snippet Cerebral endothelial cell (EC) injury and blood-brain barrier (BBB) permeability contribute to neuronal injury in acute neurological disease states....
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
SubjectTerms Blood-Brain Barrier - metabolism
Blood-Brain Barrier - pathology
Brain - metabolism
Brain - pathology
Brain Neoplasms - pathology
Brain Neoplasms - therapy
Endothelial Cells - metabolism
Endothelial Cells - pathology
Female
Glioblastoma - pathology
Glioblastoma - therapy
Humans
Male
Microbubbles
Middle Aged
Neuroscience
Tight Junctions
Ultrasonic Waves
Vascular biology
Title Endothelial response to blood-brain barrier disruption in the human brain
URI https://www.ncbi.nlm.nih.gov/pubmed/39724015
https://www.proquest.com/docview/3149540183
https://pubmed.ncbi.nlm.nih.gov/PMC11949064
https://doaj.org/article/5863cf26eafb412aba611190a296dd61
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1JS8QwFA7iyYsobnUjgjep0yXNclQZGQU9KXgL2Yoj0pFZ_r_vJTPDjAhepLc0Jen70uT7mrz3CLk0wvkWt_6FsDxnwde5VUHkIohaskYW3KCD89MzH7yyx7fmbSXVF54JS-GBk-F6jeS1ayseTGtZWRlrOHyeqjCV4t4n4VOoYkVMxb8roPiKRi68ZETV-3BDoLITVLzXpcQQNWsrUQzY_xvL_HlYcmX1ud8h23PaSG9Sd3fJRuj2yEO_8-hA9QljiI7TYddApyOaTqNbzP5ArRljUjrqh5PxLM4PFErhKRrT89FYa5-83vdf7gb5PDVC7uDFprlxpWHKcQf8wDIjStcAGBWG7-N1YWu4GGDAvJDBKeccs8iNHJehNgEoxQHZ7EZdOCIUNE0LMyL3ygRWtI2xpRHoaB6sUqH0GblamEl_pQgYOioHUWkwqp4bVSejZuQWLbmsidGrYwFgqueY6r8wzcjFAgcNox23MEwXRrOJrlHQgSSUdUYOEy7LpoBZAT0pm4zINcTW-rJ-pxu-x4ja0DhTQM6O_6P3J2SrwiTB6PfOTsnmdDwLZ8BcpvY8DtJv3mbvjw
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endothelial+response+to+blood-brain+barrier+disruption+in+the+human+brain&rft.jtitle=JCI+insight&rft.au=Gould%2C+Andrew&rft.au=Luan%2C+Yu&rft.au=Hou%2C+Ye&rft.au=Korobova%2C+Farida+V.&rft.date=2025-02-24&rft.issn=2379-3708&rft.eissn=2379-3708&rft.volume=10&rft.issue=4&rft_id=info:doi/10.1172%2Fjci.insight.187328&rft.externalDBID=n%2Fa&rft.externalDocID=10_1172_jci_insight_187328
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2379-3708&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2379-3708&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2379-3708&client=summon